KREBS BIOCHEMINDS (India) Today

Equity ratings for KREBS BIOCHEMINDS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of June 2021 and ending today, the 21st of September 2021. Click here to learn more.
KREBS BIOCHEMINDS cannot be verified against its exchange. Apparently, KREBS BIOCHEMINDS is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

KREBS BIOCHEMINDS Stock Profile

Krebs Biochemicals Industries Limited manufactures and sells active pharmaceutical ingredients in India. Krebs Biochemicals Industries Limited was founded in 1991 and is headquartered in Hyderabad, India. KREBS BIOCHEMINDS is traded on National Stock Exchange of India in India.. The public information regarding KREBS BIOCHEMINDS's current market price is not available at this time.
KREBS BIOCHEMINDS is not yet fully synchronised with the market data
KREBS BIOCHEMINDS has some characteristics of a very speculative penny stock
KREBS BIOCHEMINDS has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 502.27 M in total debt. KREBS BIOCHEMINDS has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported the revenue of 477.58 M. Net Loss for the year was (200.12 M) with profit before overhead, payroll, taxes, and interest of 88.58 M.
Legal NameKREBS BIOCHEMINDS
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of KREBS BIOCHEMINDS's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
KREBS BIOCHEMINDS (KREBSBIO) is traded on National Stock Exchange of India in India and employs 408 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate KREBS BIOCHEMINDS's market, we take the total number of its shares issued and multiply it by KREBS BIOCHEMINDS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. KREBS BIOCHEMINDS operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 16.63 M outstanding shares.
Check KREBS BIOCHEMINDS Probability Of Bankruptcy

KREBS Stock Against Markets

Picking the right benchmark for KREBS BIOCHEMINDS stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in KREBS BIOCHEMINDS stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for KREBS BIOCHEMINDS is critical whether you are bullish or bearish towards KREBS BIOCHEMINDS at a given time.
KREBS BIOCHEMINDS cannot be verified against its exchange. Apparently, KREBS BIOCHEMINDS is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with KREBS BIOCHEMINDS stock to make a market-neutral strategy. Peer analysis of KREBS BIOCHEMINDS could also be used in its relative valuation, which is a method of valuing KREBS BIOCHEMINDS by comparing valuation metrics with similar companies.
Check out Stocks Correlation. Note that the KREBS BIOCHEMINDS information on this page should be used as a complementary analysis to other KREBS BIOCHEMINDS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Tools for KREBS Stock

When running KREBS BIOCHEMINDS price analysis, check to measure KREBS BIOCHEMINDS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KREBS BIOCHEMINDS is operating at the current time. Most of KREBS BIOCHEMINDS's value examination focuses on studying past and present price action to predict the probability of KREBS BIOCHEMINDS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move KREBS BIOCHEMINDS's price. Additionally, you may evaluate how the addition of KREBS BIOCHEMINDS to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go